Abstract:To die or not to die—that is the question. Up to date, there is accumulating evidence that in addition to necrosis, the programmed cell death plays a significant role in acute or delayed neuronal death in the central nervous system (CNS) disorders, such as neurodegenerative diseases and ischemic stroke. After focusing on necrosis and apoptosis as the major causes of neuronal death in the CNS disorders for dozens of years, it has been recognized that elaborating the mechanisms underlying neuronal death is not as easy as it looks. In recent years, autophagy has become one of the most attractive topics in the research of neuronal death of CNS disorders. The term autophagy comes from the Greek roots “auto” (self) and “phagy” (eating) and means selfdigestion. Previously, autophagy has been viewed as type II programmed cell death with a random process because it appears to engulf cytosol indiscriminately; however, it is now recognized as a tightly regulated endogenous biological response to degrade damaged and dysfunctional cellular organelles and protein aggregates. In neuronal cells, approximately 1% of cellular proteins are catabolized per hour by autophagy, even under nutrient-rich condition. Although it is not fully understood how much the basal autophagy contributes to macromolecule synthesis and energy production in the steady state by supplying amino acids, glucose, and free fatty acids, the role of basal autophagy acting as the quality-control machinery for cytoplasmic components is widely accepted [1]. Many neurodegenerative disorders, such as Parkinson disease (PD) and Alzheimer’s disease (AD), result from proteins that increase their propensity to form aggregates. While autophagy can eliminate aggregated proteins, defective mitochondria, and excessive reactive oxygen species (ROS) that could induce DNA damage and cell death, inadequate or defective autophagy promotes neuronal cell death in most of neurodegenerative disorders. It is becoming increasingly evident that the cell response may shift gradually from elimination of damaged proteins/organelles by autophagy, which leads to its recovery, to the induction of apoptotic or necrotic pathways determining cellular demise under both neurodegenerative disorders and brain ischemia (Figure 1). p62, a hot topic in cell death research in recent years, is a scaffolding protein that binds to polyubiquitin and associated with the nuclear envelope. Previous works reveal that p62 acts as a signaling hub through its ability to recruit and oligomerize important signaling molecules in cytosolic speckles to control cell apoptosis [2]. Thus, p62 is thought to be a detrimental player in the cell life [2]. However, this opinion is being challenged. Recently, p62 was found to be localized to autophagic compartments via preferential binding with LC3-II form, which may assist in removal of cellular proteins damaged by dopaminergic neurotoxin [3] and is involved in the decrease of the neuronal cell number under hypoxic stress [4]. p62 was also reported to be a potential diagnostic tool for Alzheimer’s disease [5]. Further, p62 is recruited to mitochondrial clusters and is essential for the clearance of mitochondria in the pathogenesis of Parkinson’s disease [6–9], although there are minor disputes regarding the detailed mechanisms underlying the effect of p62 on the dysfunctional mitochondrial clustering and mitophagy [6–9]. Thus, whether p62 is a detrimental or a beneficial factor for the survival of neuronal cell depends on the pathological insults and the tissue microenvironment and the switch between autophagy and apoptosis, which is regulated by p62. Autophagy also participates in the cerebral ischemia-induced injury. Accumulating data supported the critical role of autophagy in cerebral ischemia as well as in neurodegenerative diseases [10 –12]. Nevertheless, autophagy may be a double-edged sword for cerebral ischemia [10–12]. We recently reviewed the beneficial and harmful effects of autophagy in cerebral ischemia [13]. In this issue of CNS Neuroscience & Therapeutics, Qi et al. describe a new role for Akt/glycogen synthase kinase 3b (GSK-3b)-dependent

A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90

The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies

Histone deacetylase 6 inhibition promotes microtubule acetylation and facilitates autophagosome–lysosome fusion in dystrophin‐deficient mdx mice

Indices of Defective Autophagy in Whole Muscle and Lysosome Enriched Fractions From Aged D2-mdx Mice

Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model

Regulatory Roles of PINK1-Parkin and AMPK in Ubiquitin-Dependent Skeletal Muscle Mitophagy

Attenuation of apoptosis in vitro and ischemia/reperfusion injury in vivo in mouse skeletal muscle by P2Y6 receptor activation

MCU-independent Ca2+ uptake mediates mitochondrial Ca2+ overload and necrotic cell death in a mouse model of Duchenne muscular dystrophy

The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells

Skeletal muscle cell protein dysregulation highlights the pathogenesis mechanism of myopathy-associated p97/VCP R155H mutations

Polymeric nanoparticles delivery of AMPK activator 991 prevents its toxicity and improves muscle homeostasis in Duchenne Muscular Dystrophy

Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model

PINK1/Parkin Pathway-Mediated Mitophagy by AS-IV to Explore the Molecular Mechanism of Muscle Cell Damage.

An unconventional autophagic pathway that inhibits ATP secretion during apoptotic cell death

Necroptosis mediates myofibre death in dystrophin-deficient mice

Lipid-mediated motor-adaptor sequestration impairs axonal lysosome delivery leading to autophagic stress and dystrophy in Niemann-Pick type C

Lysosomal Two-Pore Channel Subtype 2 (TPC2) Regulates Skeletal Muscle Autophagic Signaling.

Deregulated mitochondrial quality control, the heel of Achilles in elucidating the role of autophagy in SARM1-mediated axon degeneration

Autophagy in the Disorders of Central Nervous System: Vital And/or Fatal?

Small-molecule Activation of Lysosomal TRP Channels Ameliorates Duchenne Muscular Dystrophy in Mouse Models

Abstract 9711: Cardioprotection by Endogenous Cardiac Myocyte P2x4; Receptors in Pressure Overload and Ischemic Heart Failure